In grade II MR1 high glioma, GO pathways, such as “positive regulation of toll-like receptor signaling, inflammatory cell apoptotic process, positive regulation of tumor necrosis factor biosynthetic process, and toll-like receptor 3 signaling pathways,” and KEGG pathways, such as “antigen processing and presentation, and systemic lupus erythematosus” were dysregulated. The gene discussed is TLR3; the disease is systemic lupus erythematosus.